Spectrum Pharma (SPPI) Prices 21.67M Share Common Offering at $3/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/29/2026
- S&P 500, Nasdaq futures edge higher ahead of Fed decision; chip stocks wobble
- How will the S&P 500 react to today’s FOMC? JPM lays out the playbook
- Oil rises as US-Iran tension escalates after Iraq strikes, missile attack
- Procter & Gamble falls on weak sales, cautious guidance
- Vertiv shares sink as Q2 revenue miss offsets upgraded guidance
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- HF Sinclair plans to spin off lubricants unit, close Canadian refinery
- S&P 500 ends higher as investors await tech earnings
- SoFi Technologies (SOFI) Tops Q2 EPS by 1c ; Offers Guidance
- NVIDIA’s rising CDS the talk of Wall Street amid circular financing fears
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- After-Hours Stock Movers: GOOGL, TSLA, NOW, IBM, TXN, MOH, URI
- After-Hours Stock Movers: SMCI, OKLO, XE, PEGA, CLDX, ALK
After-Hours Movers 07/29: (HOME) (APA) (PYPL) Higher; (JAKK) (SPPI) (NOW) Lower (more...)
July 29, 2020 6:14 PM EDTAfter-Hours Stock Movers
At Home Group (NYSE: HOME) 46% HIGHER; reported revenue for the quarter of $515 million versus the consensus estimate of $360.87 million. Comparable store sales increase of approximately 42%.
JAKKS Pacific (NASDAQ: JAKK) 16.7% LOWER; reported Q2 adj. EPS of ($4.38), $0.32 worse than the analyst estimate of ($4.06). Revenue for the quarter came in at $78.8 million versus the consensus estimate of $79.5 million.
Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) 16.4% HIGHER; Spring Bank and F-star Therapeutics,... More
Spectrum Pharma (SPPI) Announces Proposed Public Offering of Common Stock
July 29, 2020 5:22 PM EDTSpectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) (Spectrum), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering. All of the shares in the offering are to be sold by Spectrum. Spectrum also... More
